News Daily News Many Lower-Income Patients Fail to Stick With Clopidogrel After PCI Todd Neale December 10, 2015
News Daily News AHA Scientific Statement Highlights Sex Disparities in CV Risk Among Diabetic Patients L.A. McKeown December 09, 2015
News Daily News NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication Michael O'Riordan December 08, 2015
News Daily News Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk Michael O'Riordan December 02, 2015
News Industry News Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled November 23, 2015
News Conference News AHA 2015 Degree of LDL Cholesterol-Lowering on High-Intensity Rosuvastatin Determines Clinical Impact Todd Neale November 12, 2015
News Conference News AHA 2015 PROMISE Analyses: Coronary CTA May Hold Some Benefits for Patients With Suspected CAD Todd Neale November 10, 2015
News Conference News AHA 2015 Knowing Genetic Risk for MI Motivates Patients, Physicians to Get Cholesterol Levels Lower Yael L. Maxwell November 08, 2015
News Daily News Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients Yael L. Maxwell November 04, 2015
News Daily News Statin Therapy Reduces Influenza Vaccine Effectiveness, Studies Suggest Yael L. Maxwell November 03, 2015
News Daily News No Money, No Drugs: Global Barriers to Secondary CVD Prevention Caitlin E. Cox October 27, 2015
News Conference News TCT 2015 IBIS-4: Rosuvastatin Tied to Plaque Stability in STEMI Yael L. Maxwell October 16, 2015
Presentation TCT 2015 Hyperlipidemic Therapy: From Statins to PCSK9 Inhibitors Presenter: George D. Dangas, Paul A. Gurbel, Joshua W. Knowles October 13, 2015
News Conference News TCT 2015 Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated October 12, 2015
News Daily News Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores Todd Neale October 08, 2015
News Industry News Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union September 28, 2015
News Daily News OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years L.A. McKeown September 23, 2015